These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 22340235)
21. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis. Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907 [TBL] [Abstract][Full Text] [Related]
22. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma]. Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315 [TBL] [Abstract][Full Text] [Related]
23. [Expression of ESM-1 in hepatocellular carcinoma is associated with angiogenesis and tumor invasion]. Xiang X; Zhao WB; Wang X Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):661-4. PubMed ID: 19785952 [TBL] [Abstract][Full Text] [Related]
24. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600 [TBL] [Abstract][Full Text] [Related]
25. [Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma]. Hou YK; Wang Y; Cong WM; Wu MC Ai Zheng; 2007 Jun; 26(6):591-5. PubMed ID: 17562263 [TBL] [Abstract][Full Text] [Related]
26. [Expression of CXCR3 in hepatocellular carcinoma]. Shi M; Guo RP; Zhang CQ; Zhong C; Lin XJ; Li JQ Ai Zheng; 2006 Oct; 25(10):1232-7. PubMed ID: 17059766 [TBL] [Abstract][Full Text] [Related]
27. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma]. Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766 [TBL] [Abstract][Full Text] [Related]
28. Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor. Tsunedomi R; Iizuka N; Tamesa T; Sakamoto K; Hamaguchi T; Somura H; Yamada M; Oka M Clin Cancer Res; 2008 Feb; 14(4):1025-31. PubMed ID: 18281534 [TBL] [Abstract][Full Text] [Related]
29. Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in hepatocellular carcinoma and metastatic liver cancer. Hotta T; Kobayashi Y; Taniguchi K; Johata K; Sahara M; Watanabe T; Ochiai M; Tanimura H; Tsubota YT Oncol Rep; 2004 Aug; 12(2):347-51. PubMed ID: 15254700 [TBL] [Abstract][Full Text] [Related]
30. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Ikeguchi M; Hirooka Y; Kaibara N Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288 [TBL] [Abstract][Full Text] [Related]
31. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma]. Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211 [TBL] [Abstract][Full Text] [Related]
32. [Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma]. Chang XJ; Wang CP; Qu JH; Lu YY; Chen Y; Bai WL; Gao XD; Hao LY; Xu GL; Wang H; Yang YP Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):748-52. PubMed ID: 23291068 [TBL] [Abstract][Full Text] [Related]
33. Expression of hepatoma-derived growth factor in hepatocellular carcinoma. Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832 [TBL] [Abstract][Full Text] [Related]
34. [Expression of vascular endothelial growth factor correlates with invasion and metastasis of hepatocellular carcinoma]. Li X; Tang Z; Zhou G Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):12-4. PubMed ID: 10921046 [TBL] [Abstract][Full Text] [Related]
35. Expression of HIWI in human hepatocellular carcinoma. Jiang J; Zhang H; Tang Q; Hao B; Shi R Cell Biochem Biophys; 2011 Sep; 61(1):53-8. PubMed ID: 21327579 [TBL] [Abstract][Full Text] [Related]
36. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues]. Chen L; Shen AG; Wang GL; Lu P; Li XY Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986 [TBL] [Abstract][Full Text] [Related]
37. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China. Dong-Dong L; Xi-Ran Z Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194 [TBL] [Abstract][Full Text] [Related]
38. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995 [TBL] [Abstract][Full Text] [Related]
39. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma. Li XM; Tang ZY; Qin LX; Zhou J; Sun HC J Exp Clin Cancer Res; 1999 Dec; 18(4):511-7. PubMed ID: 10746978 [TBL] [Abstract][Full Text] [Related]
40. [Expression and clinical significance of HIF-1a protein in hepatocellular carcinoma tissues]. Ding L; Chen XP; Wang HP Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):656-9. PubMed ID: 15623372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]